| Year |
Citation |
Score |
| 2024 |
Alleva DG, Delpero AR, Sathiyaseelan T, Murikipudi S, Lancaster TM, Atkinson MA, Wasserfall CH, Yu L, Ragupathy R, Bonami RH, Zion TC. An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes. Frontiers in Immunology. 15: 1367514. PMID 38515750 DOI: 10.3389/fimmu.2024.1367514 |
0.708 |
|
| 2024 |
Alleva DG, Feitsma EA, Janssen YF, Boersma HH, Lancaster TM, Sathiyaseelan T, Murikipudi S, Delpero AR, Scully MM, Ragupathy R, Kotha S, Haworth JR, Shah NJ, Rao V, Nagre S, et al. Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine. Npj Vaccines. 9: 40. PMID 38383578 DOI: 10.1038/s41541-024-00830-2 |
0.728 |
|
| 2023 |
Feitsma EA, Janssen YF, Boersma HH, van Sleen Y, van Baarle D, Alleva DG, Lancaster TM, Sathiyaseelan T, Murikipudi S, Delpero AR, Scully MM, Ragupathy R, Kotha S, Haworth JR, Shah NJ, et al. A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452. Vaccine. PMID 36842886 DOI: 10.1016/j.vaccine.2023.02.057 |
0.729 |
|
| 2022 |
Hulsebosch SE, Pires J, Bannasch MJ, Lancaster T, Delpero A, Ragupathy R, Murikipudi S, Zion T, Gilor C. Ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs. Journal of Veterinary Internal Medicine. PMID 35621084 DOI: 10.1111/jvim.16449 |
0.717 |
|
| 2022 |
Janssen YF, Feitsma EA, Boersma HH, Alleva DG, Lancaster TM, Sathiyaseelan T, Murikipudi S, Delpero AR, Scully MM, Ragupathy R, Kotha S, Haworth JR, Shah NJ, Rao V, Nagre S, et al. Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452. Vaccine. 40: 1253-1260. PMID 35115195 DOI: 10.1016/j.vaccine.2022.01.043 |
0.739 |
|
| 2021 |
Alleva DG, Delpero AR, Scully MM, Murikipudi S, Ragupathy R, Greaves EK, Sathiyaseelan T, Haworth JR, Shah NJ, Rao V, Nagre S, Lancaster TM, Webb SS, Jasa AI, Ronca SE, et al. Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452. Vaccine. PMID 34642088 DOI: 10.1016/j.vaccine.2021.09.077 |
0.728 |
|
| 2021 |
Gilor C, Hulsebosch SE, Pires J, Bannasch MJ, Lancaster T, Delpero A, Ragupathy R, Murikipudi S, Zion T. An ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in cats. Journal of Veterinary Internal Medicine. PMID 34190365 DOI: 10.1111/jvim.16150 |
0.715 |
|
| 2008 |
García-Martínez J, Lancaster T, Ying J. Synthesis and Catalytic Applications of Self-Assembled Carbon Nanofoams Advanced Materials. 20: 288-292. DOI: 10.1002/Adma.200602977 |
0.449 |
|
| 2005 |
Lancaster TM, Lee SS, Ying JY. Effect of surface modification on the reactivity of MCF-supported IndaBOX. Chemical Communications (Cambridge, England). 3577-9. PMID 16010329 DOI: 10.1039/B506205E |
0.425 |
|
| 2005 |
Lettow JS, Lancaster TM, Glinka CJ, Ying JY. Small-angle neutron scattering and theoretical investigation of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) stabilized oil-in-water microemulsions. Langmuir : the Acs Journal of Surfaces and Colloids. 21: 5738-46. PMID 15952817 DOI: 10.1021/La046918B |
0.605 |
|
| Show low-probability matches. |